![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 22, 2014 9:25:20 AM
thank you Kenbe!
SCHEDULE 1 (CLASS I) DRUGS are illegal because they have high abuse potential, no medical use, and severe safety concerns; for example, narcotics such as Heroin, LSD, and cocaine. Marijuana is also included as a Class 1 drug despite it being legal in some states and it being used as a medicinal drug in some states.
SCHEDULE 2 DRUGS (CLASS 2) DRUGS have a high potential for abuse and dependence, an accepted medical use, and the potential for severe addiction. These drugs include opiods based on high dose codeine, Fentanyl, and Oxycodone as well as Methamphetamine and the Barbiturates; also included are such drugs as opium, morphine. Adderall is even included in this category under "mixed amphetamine salts".
The main difference between a Schedule, or Class, 1 and 2 is whether or not the drug is deemed to have a valid medical application.
SCHEDULE 3 (CLASS 3) DRUGS have a lower potential for abuse than drugs in the first two categories, accepted medical use, and mild to moderate possible addiction. These drugs include steroids, Low-dose Codeine, and Hydrocodone-based opiods.
SCHEDULE 4 (CLASS 4) DRUGS have an even lower abuse potential than Schedule 3 Drugs, accepted medical use, and limited addiction potential. These include most of the anti-anxiety medications like the numerous Benzodiazepines, Sedatives, sleeping agents, and the mildest of the opiod type medications like Darvon and Talwin.
SCHEDULE 5 (CLASS 5) DRUGS have a low abuse potential, accepted medical use, and a very limited addiction potential. These consist primarily of preparations containing limited quantities of narcotics or stimulant drugs for cough, diarrhea, or pain.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM